CTRI/2023/05/052494尚未招募Unknown
A Descriptive study of Cutaneous Adverse Drug Reactions with Causality, Severity and Preventability Assessment at SMS Hospital, Jaipur
Yatendra singh0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1.Patients attending dematology out-patient department with cutaneous adverse drug reactions.
- •2.Patients who agree to give informed consent.
排除标准
- •1.Patients with viral exanthemas.
- •2.Patients who cant recall their medication details.
研究者
相似试验
已完成
不适用
Study for association with dermatological adverse event induced by molecular targeted drugs and profile of body weigh dispersiometastatic renal cell cancerJPRN-UMIN000018948Department of Pharmacy, Kobe University Hospital30
已完成
不适用
Evaluation of dermato-pharmacokinetics after repeated application of lanoconazole -whole day application 5days repeated trialhealthy volunteerJPRN-UMIN000019856Dept of Clinical Pharmacology & Therapeutics, Oita University Faculty of Medicine12
已完成
不适用
Evaluation of dermato-pharmacokinetics after repeated application of lanoconazolehealthy volunteerJPRN-UMIN000016466Dept of Clinical Pharmacology & Therapeutics, Oita University Faculty of Medicine12
尚未招募
不适用
clinical and histopathological study of drug reactions in skiCTRI/2020/03/023893Dr Amulya s
尚未招募
不适用
Rate of severe cutaneous adverse reactions due to first line Anti-tuberculosis drugs, Health Product Vigilance Center database; Food and Drug Administration, Ministry of Public Healthsevere cutaneous adverse reactionsSCARscutaneous adversed reactionsantituberculosisfirst line antituberculosis drugsSJSTENDRESSAGEPsevere cutaneous adverse reactionsSCARscutaneous adversed reactionsantituberculosisfirst line antituberculosis drugsDRESSAGEPSJSTENTCTR20180812003Tipsiri Chaikong3,500